You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Recent Transactions
Advisors & Consultants
Clients
Financials
Awards & Honors

Microbix Biosystems Inc.

OVERVIEW

Date Founded
1988
Headquarters
265 Watline Avenue, Mississauga, On, L4z 1p3, Can
Type of Company
Public
Employees (Worldwide)
69
Industries
Biotechnology

Hospitals & Patient Services
Company Description
Microbix Biosystems, Inc. manufactures viral and bacterial antigens and reagents for the global diagnostics industry. Its biological solutions include products for human health applications in the vaccine, therapeutic and diagnostic markets and a product for the worldwide animal reproduction market. Its pipeline of technologies and products include LumiSort, semen sexing technology for the livestock industries; Kinlytic, a thrombolytic drug for life-threatening blood clots; and VIRUSMAX, a proprietary technology for increasing virus yields in the manufacture of influenza vaccine. The company was founded by William J. Gastle in 1988 and is headquartered in Mississauga, Canada.
Website

In The News See more

News Bites Canadian Markets
November 21, 2017
News Bites Canadian Markets
November 20, 2017
News Bites Canadian Markets
November 17, 2017
News Bites Canadian Markets
November 13, 2017
News Bites Canadian Markets
November 8, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees


Chief Executive Officer, President & Director

Executive Director

Chief Financial Officer

Secretary & General Counsel

Director of Research & Development

Senior Vice President, Scientific Affairs

Senior Vice President-Sales, Marketing & Business Development

Vice President, BioPharmaceuticals

Vice President Diagnostic Products
See our list of current and previous employees when you upgrade.

Board of Directors


Founder at Microbix Biosystems Inc.

Chief Executive Officer & Director at Zydus Pharmaceuticals USA, Inc.

Chief Executive Officer, President & Director at Microbix Biosystems Inc.

Former General Counsel at Merck KGaA

Founding Partner at NeuroVentures Capital LLC

Director-Interventional Training at AIM Health Group, Inc.

Executive Director at Microbix Biosystems Inc.
See our list of current and previous board members when you upgrade.

Paths to Microbix Biosystems Inc.

Microbix Biosystems Inc.
You
Connections via Relationship Science
Microbix Biosystems Inc.
Sync your contacts to see how you can connect with Microbix Biosystems Inc..

Recent Transactions

Details Hidden
Microbix Biosystems Inc. raised money in a private placement transaction
Details Hidden
Microbix Biosystems Inc. raised money in a private placement transaction
Details Hidden
Microbix Biosystems Inc. purchases ImaRx Therapeutics, Inc. /Urokinase Bus from ImaRx Therapeutics, Inc.

Advisors & Consultants

People ▾
Advisor

Former Chief Financial Officer at Microbix Biosystems Inc.

Clients

Companies ▾
   Cincinnati, OH
Meridian Bioscience, Inc. is a fully integrated life science company, which engages in the development, manufacture, sale, and distribution of diagnostic test kits, purified reagents, and related products and offers biopharmaceutical enabling technologies. It operates through the Diagnostics and Life Science segments. The Diagnostics segment comprises of manufacturing operations in Cincinnati, Ohio, and the sale and distribution of diagnostic test kits in the US, Europe, Africa and the Middle East. The Life Science operating segment consists of manufacturing operations in Memphis, Tennessee; Saco, Maine; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia and the sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bioresearch reagents domestically and abroad. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

Key Stats and Financials as of 9/30/2016

Market Capitalization
$28.9M
Total Enterprise Value
$29.6M
Earnings Per Share
$0.01
Revenue
$9.52M
Net Profit
$750K
EBITDA
$1.25M
EBITDAMargin
13.16%
Total Debt
$9.73M
Total Equity
$12.9M
Enterprise Value Sales
3.11x
Enterprise Value EBITDAOperating
23.65x
TEVNet Income
39.58x
Debt TEV
0.33x
Three Year Compounded Annual Growth Rate Of Revenue
7.91%
Five Year Compounded Annual Growth Rate Of Revenue
8.85%
See financial details and more using RelSci Professional.

Awards & Honors

CA (Chartered Accountant)

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.